BioMarin Pharmaceutical Inc.
US ˙ NasdaqGS ˙ US09061G1013

SecurityBMRN / BioMarin Pharmaceutical Inc.
InstitutionAllworth Financial LP
Latest Disclosed Ownership7,598 shares
Latest Disclosed Value $ 429,212
Allworth Financial LP reports 49.27% increase in ownership of BMRN / BioMarin Pharmaceutical Inc.

On May 14, 2026 - Allworth Financial LP filed a 13F-HR form disclosing ownership of 7,598 shares of BioMarin Pharmaceutical Inc. (US:BMRN) valued at $429,211 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 5,090 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of 49.27% during the quarter. The current value of the position is $415,307 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 7,598 2,508 49.27 429 42.05 0.0017
2026-02-05 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,090 889 21.16 302 33.04 0.0012
2025-12-02 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,201 1,557 58.89 228 56.55 0.0010
2025-08-07 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,644 851 47.46 145 29.46 0.0007
2025-04-30 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,793 -111 -5.83 112 -5.08 0.0006
2025-01-30 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,904 127 7.15 118 -4.84 0.0006
2024-10-23 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,777 -191 -9.71 125 -24.85 0.0008
2024-07-24 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,968 4 0.20 165 -3.51 0.0011
2024-04-25 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,964 1,360 225.17 172 194.83 0.0012
2024-01-24 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 604 214 54.87 58 70.59 0.0004
2023-10-31 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 390 44 12.72 35 17.24 0.0003
2023-07-18 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 346 -10 -2.81 30 -14.71 0.0003
2023-04-18 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 356 130 57.52 35 47.83 0.0003
2023-01-13 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 226 27 13.57 23 35.29 0.0003
2022-11-14 2022-09-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 199 39 24.38 17 30.77 0.0002
2022-10-18 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 199 39 17 0.0002
2022-07-13 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 160 -102 -38.93 13 -35.00 0.0002
2022-04-22 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 262 0 0.00 20 -13.04 0.0003
2022-01-21 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 262 0 0.00 23 15.00 0.0003
2021-11-02 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 262 126 92.65 20 81.82 0.0003
2021-08-02 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 136 -25 -15.53 11 -8.33 0.0002
2021-04-29 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 161 21 15.00 12 0.00 0.0002
2021-01-26 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 140 0 0.00 12 9.09 0.0003
2020-11-03 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 140 25 21.74 11 -21.43 0.0003
2020-07-24 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 115 0 0.00 14 40.00 0.0004
2020-04-17 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 115 0 0.00 10 0.00 0.0003
2020-01-16 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 115 115 10 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.